tiprankstipranks
Mydecine Innovations Group, Inc. (TSE:MYCO)
:MYCO
Canadian Market
Holding TSE:MYCO?
Track your performance easily

Mydecine Innovations Group (MYCO) Financial Statements

97 Followers

Mydecine Innovations Group Financial Overview

Mydecine Innovations Group's market cap is currently ―. The company's EPS TTM is C$-0.274; its P/E ratio is ―; Mydecine Innovations Group is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.60M$ -2.30M$ -665.22K$ 1.23M$ -2.32M
EBITDA$ -1.60M$ -2.30M$ -665.22K$ 1.23M$ -2.32M
Net Income Common Stockholders$ -1.99M$ -2.67M$ -1.02M$ -17.62M$ -2.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 60.17K$ 13.61K$ 20.35K$ 37.65K$ 40.46K
Total Assets$ 178.31K$ 158.52K$ 213.41K$ 212.38K$ 1.03M
Total Debt$ ―$ ―$ ―$ ―$ 5.25M
Net Debt$ ―$ ―$ ―$ ―$ 5.21M
Total Liabilities$ 17.62M$ 15.61M$ 13.05M$ 12.13M$ 10.11M
Stockholders Equity$ -17.45M$ -15.45M$ -12.84M$ -11.92M$ -9.08M
Cash Flow-
Free Cash Flow$ 49.57K$ -9.75K$ -17.30K$ 951.81K$ -819.54K
Operating Cash Flow$ 49.57K$ -9.75K$ -17.30K$ 951.81K$ -819.54K
Investing Cash Flow---$ 1.00$ 25.20K
Financing Cash Flow---$ -931.50K$ 824.50K
Currency in USD

Mydecine Innovations Group Earnings and Revenue History

Mydecine Innovations Group Debt to Assets

Mydecine Innovations Group Cash Flow

Mydecine Innovations Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis